Announcements and Notices - [Change in Registered Address or Office, Registered Place of Business in HK or Agent for Service of Process in HK]

Keymed Biosciences Inc. operates a biotechnology company. The Company focus on the in-house discovery and development of innovative biological therapies. Keymed Biosciences provides services in China.

Change Of Principal Place Of Business In Hong Kong

Announcements and Notices - [Other - Business Update]

Voluntary Announcement
The Latest Data From The Phase I/Ii Clinical Study Of
Cm336 At The 66th American Society Of Hematology
 (Ash) Annual Meeting By Way Of A Poster

Voluntary Announcement
Exclusive License Agreement For Cm336

Financial Statements/ESG Information - [Interim/Half-Year Report]

2024 Interim Report

Announcements and Notices - [Inside Information]

Inside Information Announcement
Stapokibart Was Granted Marketing Approval From
National Medical Products Administration For The
Treatment Of Moderate-To-Severe
Atopic Dermatitis In Adults

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Change Of Principal Place Of Business In Hong Kong

Voluntary Announcement The Latest Data From The Phase I/Ii Clinical Study Of Cm336 At The 66th American Society Of Hematology (Ash) Annual Meeting By Way Of A Poster

Voluntary Announcement Exclusive License Agreement For Cm336

2024 Interim Report

Inside Information Announcement Stapokibart Was Granted Marketing Approval From National Medical Products Administration For The Treatment Of Moderate-To-Severe Atopic Dermatitis In Adults